NEW YORK (GenomeWeb) – Brigham Young University is using Tute Genomics' genome annotation and interpretation platform to analyze next generation sequencing data from an Alzheimer's disease research project.
BYU will use the platform, Tute said, to analyze genetic data from more than 1000 exomes and genomes to identify new genetic variants associated with Alzheimers. Specifically, a research team led by John Kauwe, an assistant professor in BYU's biology department, is using the platform to identify potential therapeutic targets. "We have been extremely impressed with the Tute platform thus far, and we already have a number of research findings we are evaluating," Kauwe said in a statement.
The BYU project is part of a larger collaborative effort called the Alzheimer's Genetic Analysis Group. Other participants in the project include University College London, Washington University School of Medicine, and the National Institutes of Health.